Compare SNOW & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNOW | WAT |
|---|---|---|
| Founded | 2012 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 33.6B |
| IPO Year | 2020 | 1996 |
| Metric | SNOW | WAT |
|---|---|---|
| Price | $158.14 | $331.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 43 | 17 |
| Target Price | $248.62 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 6.2M | 1.1M |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,683,946,000.00 | N/A |
| Revenue This Year | $28.57 | $104.66 |
| Revenue Next Year | $23.41 | $10.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 29.16 | N/A |
| 52 Week Low | $118.30 | $275.05 |
| 52 Week High | $280.67 | $414.15 |
| Indicator | SNOW | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.64 | 52.52 |
| Support Level | $155.35 | $284.02 |
| Resistance Level | $186.62 | $341.22 |
| Average True Range (ATR) | 6.71 | 12.00 |
| MACD | 2.07 | 0.77 |
| Stochastic Oscillator | 93.40 | 63.18 |
Snowflake Inc Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflakes cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The companies data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.